InvestorsHub Logo
Followers 144
Posts 27607
Boards Moderated 3
Alias Born 02/07/2004

Re: midastouch017 post# 1579

Sunday, 01/08/2017 11:11:06 AM

Sunday, January 08, 2017 11:11:06 AM

Post# of 1834
Clal Biotechnology is reporting a number of recent deals and developments by its portfolio companies, including the completion by Gamida Cell of procedures for another trial on patients with leukemia or lymphoma for the US Food and Drug Administration (FDA). Gamida Cell has also obtained FDA approval for a personalized vaccination against mutations created by the malignant tumor itself.

Published by Globes [online], Israel Business News - www.globes-online.com - on January 8, 2017

http://www.globes.co.il/en/article-neon-therapeutics-completes-70m-financing-round-1001170762